Views & Analysis Nontuberculous mycobacteria – an emerging public health prob... The challenge of treating Nontuberculous mycobacteria.
News Bambusa, Aspen, and Tang added to IPO pipeline 2026's sizeable haul of IPOs shows no signs of letting up, with three more biotechs – Bambusa, Aspen, and blank cheque firm Tang – joining the queue.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
